Infection requiring systemic antibiotic therapy or other serious infection within  days before registration
Active systemic infection requiring parenteral antibiotic therapy; all prior infections must have resolved following optimal therapy
Active infection requiring systemic antibiotic therapy.
Active infection requiring systemic antibiotic therapy
Active systemic infection requiring parenteral antibiotic therapy. All prior infections must have resolved following optimal therapy
Active infection requiring systemic antibiotic therapy.
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
Patients who have an infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment are not eligible
Subjects with active infection requiring antibiotic therapy
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
Active infection requiring systemic antibiotic therapy
Active infection requiring systemic antibiotic therapy.
Must be free of systemic infection; subjects with active infections (whether or not they require antibiotic therapy) may be eligible after complete resolution of the infection; subjects on antibiotic therapy must be off antibiotics for at least  days before beginning treatment
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
Has an active infection requiring systemic antibiotic therapy at time of enrollment\r\n* Treatment with antibiotic prophylaxis for indwelling biliary stent(s) or peri-procedural antibiotics for uncomplicated biliary stent exchanges is allowed and not an exclusion
Infection requiring intravenous antibiotic therapy or other serious infection within  days before study enrollment
Active infection requiring systemic antibiotic therapy
Must be free of systemic infection; subjects with active infections (whether or not they require antibiotic therapy) may be eligible after complete resolution of the infection; subjects on antibiotic therapy must be off antibiotics for at least  days before beginning treatment
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
Infection requiring intravenous (IV) antibiotic therapy or other serious infection within  days before randomization.
Active infection requiring systemic antibiotic therapy.
EXCLUSION - PARTICIPANT: Active infection requiring systemic antibiotic therapy. Participants requiring systemic antibiotics for infection must have completed therapy before treatment is initiated.
Infection requiring systemic antibiotic therapy or other serious infection within  days before study drug administration
Must be free of systemic infection:\r\n* Subjects with active infections (whether or not they require antibiotic therapy) may be eligible after complete resolution of the infection\r\n* Subjects on antibiotic therapy must be off antibiotics for at least  days before beginning treatment
Active serious infections in particular if requiring systemic antibiotic or antimicrobial therapy
Infection requiring systemic intravenous antibiotic therapy or other serious infection within  days before study enrollment
Serious infection requiring parenteral antibiotic therapy or any other serious infection within  days before randomization.
Infection requiring intravenous antibiotic use within one week of enrollment.
Subjects must not have a known active infection requiring intravenous antibiotic therapy
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
Active serious infections in particular if requiring systemic antibiotic or antimicrobial therapy
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
DONOR: Evidence of infection not responding to antibiotic therapy
Systemic infection requiring intravenous (IV) antibiotic therapy =<  days prior to registration
Systemic infection requiring intravenous (IV) antibiotic therapy within  days preceding the first dose of study drug, or other severe infection
Active infection requiring intravenous (IV) antibiotic usage within the last week prior to study treatment
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
PHASE I: Patients should be free of active infection requiring antibiotic therapy (except for uncomplicated urinary tract infections)
PHASE II: Patients should be free of active infection requiring antibiotic therapy (except for uncomplicated urinary tract infections)
Has an active infection requiring intravenous antibiotic therapy
Infection requiring systemic antibiotic therapy or other serious infection within  days prior to start of study treatment
Any antibiotic therapy or evidence of infection within  week of registration
Active infection requiring intravenous (IV) antibiotic usage within the last week prior to the dosimetry portion of the study
Infection requiring systemic IV antibiotic therapy within  days before cycle  day  of therapy
Infection requiring current intravenous antibiotic therapy; the PI will serve as the final arbiter regarding eligibility
Evidence of active infection requiring antibiotic therapy ?  days prior to the first dose of PRTX- 
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
Must be free of systemic infection; subjects with active infections (whether or not they require antibiotic therapy) may be eligible after complete resolution of the infection; subjects on antibiotic therapy must be off antibiotics for at least  days before beginning treatment
Systemic infection requiring intravenous (IV) antibiotic therapy within  days preceding the first dose of study drug, or other severe infection
Active infection requiring systemic antibiotic therapy. Patients requiring systemic antibiotics for infection must have completed therapy before Screening is initiated
Patients who have evidence of active infection that requires antibiotic therapy; patients must have been off antibiotic treatment for at least  weeks prior to initiating treatment and must be confirmed to be clear of the infection; if patient develops an infection requiring antibiotic treatment while on the treatment portion of the study patients will be treated for the active infection with antibiotics and will resume vaccine treatment when the infection is healed
Has an active infection requiring systemic therapy NOTE: Antibiotic therapy must have been completed a minimum of  days prior to start of study treatment;
Active systemic infection requiring parenteral antibiotic therapy
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment.
Infection requiring intravenous antibiotic use within  week.
Concurrent serious infections (i.e., requiring an intravenous antibiotic)
Infection requiring systemic antibiotic therapy within  days prior to the start of study treatment
Active infection requiring IV antibiotic usage within the last week prior to study treatment
Infection requiring intravenous antibiotic use within  week.
Infection requiring systemic antibiotic therapy or other serious infection ?  days prior to registration
Has an active infection requiring systemic therapy; prior to dosing with REGN the subject must be at least  half-lives from their last dose of antibiotic
Evidence of ongoing or active infection requiring antibiotic therapy
Active infection requiring systemic antibiotic therapy.
Acute/chronic infections, open wounds, or any active infection requiring intravenous antibiotic therapy =<  weeks prior to registration
Any active infection requiring antibiotic therapy within  weeks of study day .
No active systemic infection requiring parenteral antibiotic therapy
Systemic infection requiring IV antibiotic therapy within  days preceding the first dose of study drug, or other severe infection
Systemic infection requiring intravenous (IV) antibiotic therapy within  days preceding the first dose of study drug, or other severe infection
Active serious infections in particular if requiring systemic antibiotic or antimicrobial therapy
Infection requiring systemic antibiotic therapy or other serious infection within  days before first dose of study drug
Serious infection requiring systemic antibiotic therapy within  days prior to study treatment.
An infection requiring antibiotic treatment within seven days of starting study treatment (day -)
Active infection requiring systemic antibiotic therapy.
Active infection requiring systemic antibiotic therapy. Patients requiring systemic antibiotics for infection must have completed therapy before Screening
Active serious infections in particular if requiring systemic antibiotic or antimicrobial therapy
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
No active serious infections in particular if requiring systemic antibiotic or antimicrobial therapy
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
Any infection requiring antibiotic or anti-viral treatment within  weeks of screening
Systemic infection requiring IV antibiotic therapy within  days preceding the first dose of study drug, or other severe infection
Systemic infection requiring intravenous (IV) antibiotic therapy within  days preceding the first dose of study drug, or other severe infection
Any infection requiring parenteral antibiotic therapy or causing fever (temperature > .F or .C) within  week prior to registration
Infection requiring intravenous (IV) antibiotic therapy or other serious infection within  days before randomization.
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
Serious infection requiring treatment with systemically administered antibiotics at the time of study entrance, or an infection requiring systemic antibiotic therapy within  days prior to the first dose of study treatment.
Subjects with clinically serious infections requiring ongoing antibiotic therapy
Active infection requiring systemic antibiotic therapy
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
Any antibiotic therapy or evidence of infection within  week of registration
Must be free of systemic infection; subjects with active infections (whether or not they require antibiotic therapy) may be eligible after complete resolution of the infection; subjects on antibiotic therapy must be off antibiotics for at least  days before beginning treatment
Infection requiring systemic antibiotic therapy or other serious infection within  days before randomization.
Patients with active infection requiring systemic therapy or who are dependent on or currently receiving antibiotics that cannot be discontinued before dosing; (Note: subjects who discontinue an antibiotic prior to dosing must wait at least  half-lives after the last dose of antibiotic before receiving any ADXS- infusion)
Current infections requiring antibiotic therapy.
Systemic infection requiring IV antibiotic therapy within  days preceding the first dose of study drug, or other severe infection
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
Concurrent serious infection requiring parenteral antibiotic therapy.
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
Known active infection requiring antibiotic treatment before the start of treatment (day )
Concurrent serious infections requiring parenteral antibiotic therapy.
Subject has systemic infection requiring intravenous (IV) antibiotic therapy within  days preceding the first dose of study drug, or other severe infection
Serious infection requiring intravenous antibiotic therapy within  days prior to study treatment
Active systemic infection requiring systemic antibiotic treatment within  hours prior to first dose of study treatment
Serious infection requiring treatment with systemically administered antibiotics at the time of study entrance, or an infection requiring systemic antibiotic therapy within  days prior to the first dose of study treatment.
Serious infection requiring treatment with systemically administered antibiotics at the time of study entrance, or an infection requiring systemic antibiotic therapy within  days prior to the first dose of study treatment.
Receiving antibiotic therapy within  days before the first dose of study treatment
Infection requiring IV antibiotic therapy or other serious infection within  days prior to first dose of study drug
Systemic infection requiring IV antibiotic therapy within  days preceding the first dose of study drug, or other severe infection
Serious infection requiring treatment with systemically administered antibiotics at the time of study entrance, or an infection requiring systemic antibiotic therapy within  days prior to the first dose of study treatment. For the HCC, HCC/BTC and BTC subgroups hepatitis C infection and hepatitis B infection if controlled with antiviral therapy are allowable.
any infection requiring antibiotic, anticoagulant, or antiplatelet agents within the past  weeks
Active infection requiring antibiotic treatment
Active infection requiring antibiotic therapy
Systemic infection requiring intravenous (IV) antibiotic therapy within  days preceding the first dose of study drug, or other severe infection
Be receiving quinolone antibiotic therapy
Systemic infection requiring IV antibiotic therapy or other serious infection within  days before the first dose of study drug.
Patients undergoing active antibiotic therapy
Require antibiotic therapy prior to oral cleaning
Patient is receiving antibiotic therapy for an active infection
Known active infection requiring antibiotic treatment
Infection requiring systemic antibiotic therapy within  days prior to start of study treatment
Active infection requiring systemic IV antibiotic therapy
Infection requiring systemic antibiotic therapy or other serious infection within  days before study enrollment
have an active infection requiring antibiotic therapy, or concomitant malignancies
Systemic infection requiring intravenous antibiotic therapy or other serious infection within  days before the first dose of study drug.